Chapters

Transcript

Video

Have studies been done looking at PCSK9 inhibitors as monotherapy in post-ACS patients with elevated LDL-C levels?

Have studies been done looking at PCSK9 inhibitors as monotherapy in post-ACS patients with elevated LDL-C levels?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

R. Scott Wright, MD

R. Scott Wright, MD

Professor of Medicine
Department of Cardiovascular Medicine
Cardiovascular Division
Mayo Clinic